A patient with xeroderma pigmentosum treated with imiquimod 5% cream [6]

Journal of the American Academy of Dermatology

Volumn 52, Issue 1, 2005, Pages 170-171

  Nijsten, Tamar ^a   Lapière, Kim ^a   Lambert, Julien ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IMIQUIMOD;

ADULT; ANTINEOPLASTIC ACTIVITY; CASE REPORT; CLINICAL FEATURE; CRYOTHERAPY; DRUG TOLERABILITY; HUMAN; LETTER; MALE; PRIORITY JOURNAL; SKIN IRRITATION; XERODERMA PIGMENTOSUM;

EID: 11144301853     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.04.046     Document Type: Article

References (5)

1. J. Norgauer, M. Idzko, E. Panther, O. Hellstern, and Y. Herouy Xeroderma pigmentosum Eur J Dermatol 13 2003 4 9
2. C. Ahrens, M. Grewe, M. Berneburg, S. Grether-Beck, X. Quilliet, and M. Mezzina Photocarcinogenesis and inhibition of intercellular adhesion molecule 1 expression in cells of DNA-repair-defective individuals Proc Natl Acad Sci U S A 94 1997 6837 6841
3. D.J. Hurwitz, L. Pincus, and T.S. Kupper Imiquimod: a topically applied link between innate and acquired immunity Arch Dermatol 139 2003 1347 1350
4. N.K. Weisberg, and M. Varghese Therapeutic response of a brother and sister with xeroderma pigmentosum to imiquimod 5% cream Dermatol Surg 28 2002 518 523
5. E. Nagore, A. Sevila, O. Sanmartin, R. Botella-Estrada, C. Requena, and C. Serra-Guillen Excellent response of basal cell carcinomas and pigmentary changes in xeroderma pigmentosum to imiquimod 5% cream Br J Dermatol 149 2003 858 861